middle.news
Firebrick Pharma’s Nasodine Trial Validated, Sales Climb but Funding Falls Short
8:27am on Wednesday 23rd of July, 2025 AEST
•
Healthcare
Read Story
Firebrick Pharma’s Nasodine Trial Validated, Sales Climb but Funding Falls Short
8:27am on Wednesday 23rd of July, 2025 AEST
Key Points
Phase 3 clinical trial results for Nasodine published in a leading medical journal
Nasodine sales in Singapore grew 23% despite off-peak season
US sales showing consecutive quarterly growth, with plans to scale up
Private placement raised only $173,000 against a $1.6 million target
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
FRE
OPEN ARTICLE